COMPANY
ANNOUNCEMENT
No. 14/2017
Tvis, 22 December 2017
NOT FOR RELEASE OR DISTRIBUTION OR PUBLICATION IN
WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED
STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION WHERE
THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL
This announcement does not
constitute a prospectus. No one should purchase any securities in
TCM Group A/S ("TCM Group" or the "Company") except on the basis of
information in the prospectus published by the Company in
connection with the offering and admission of such securities to
trading and official listing on Nasdaq Copenhagen A/S. Copies of
the prospectus are available at the Company's registered office
and, subject to certain exceptions, through the website of the
Company.
Exercise in part of the
overallotment option in connection with the initial public offering
and admission to trading and official listing of the shares of TCM
Group A/S. Total offering size increased to DKK 713.6
million
With reference to announcement no. 3/2017
regarding pricing of the initial public offering of the shares of
TCM Group (the "Offering") and the prospectus published by TCM
Group on 13 November 2017, TCM Group today announces that Carnegie
Investment Bank, filial af Carnegie Investment Bank AB (Publ),
Sverige ("Carnegie"), in its capacity as Stabilising Manager in the
Offering, has partly on behalf of the Joint Bookrunners exercised
the overallotment option with 282,037 additional shares at the
offer price of DKK 98 per share from the Company's major
shareholder, Innovator International S.à r.l.
As a result, the total number of shares offered in
the Offering amounts to 7,282,037 shares, thereby increasing the
total offering size to DKK 713,639,628.
Carnegie is together with Danske Bank A/S acting
as Joint Global Coordinators, and Carnegie and Danske Bank A/S are
together with ABG Sundal Collier ASA Denmark, filial af ABG Sundal
Collier ASA, Norge acting as Joint Bookrunners.
For additional information,
please contact:
CEO, Ole Lund Andersen, TCM Group, +45 97 43 52 00
About TCM Group
TCM Group is Scandinavia's third largest manufacturer of kitchens
and furniture for bathrooms and storage. The products are Danish
design, produced in Denmark and rooted in a proud tradition of good
quality and good craftsmanship. TCM Group pursues a multi-brand
strategy, under which the main brand is Svane Køkkenet and the
other brands are Tvis, Nettoline and kitchn. Combined, the brands
cater for the entire price spectrum, and are sold through 125
dealers in Denmark and the rest of the Scandinavia. In addition,
TCM Group sells private label kitchens through a total of more than
150 DIY stores in Denmark and independent kitchen stores in Norway.
See www.tcmgroup.dk for more information.
Important notice
This announcement is not an offer to sell or a
solicitation of any offer to buy any securities issued by TCM Group
A/S (the "Company") in any jurisdiction where such offer or sale
would be unlawful, and the announcement and the information
contained herein are not for distribution or release, directly or
indirectly, in or into such jurisdictions.
In any member state of the European Economic Area
("EEA Member State"), other than Denmark, that has implemented
Directive 2003/71/EC as amended (together with any applicable
implementing measures in any member state, the "Prospectus
Directive"), this announcement is only addressed to and is only
directed at investors in that EEA Member State who fulfil the
criteria for exemption from the obligation to publish a prospectus,
including qualified investors within the meaning of the Prospectus
Directive as implemented in each such EEA Member State.
Any securities referred to herein have not been
and will not be registered under the U.S. Securities Act of 1933,
as amended (the "Securities Act"), and may not be offered or sold
in the United States absent registration or an exemption from, or
in a transaction not subject to, the registration requirements of
the Securities Act. There is no intention to register any
securities referred to herein in the United States or to make a
public offering of the securities in the United States.
In the United Kingdom, this announcement and any
other materials in relation to the securities described herein are
only being distributed to, and are only directed at, and any
investment or investment activity to which this announcement
relates is available only to, and will be engaged in only with,
"qualified investors" (as defined in section 86(7) of the Financial
Services and Markets Act 2000) and who are (i) persons having
professional experience in matters relating to investments who fall
within the definition of "investment professionals" in Article
19(5) of the Financial Services and Markets Act 2000 (Financial
Promotion) Order 2005 (the "Order"); or (ii) high net worth
entities falling within Article 49(2)(a) to (d) of the Order (all
such persons together being referred to as "relevant persons").
Persons who are not relevant persons should not take any action on
the basis of this announcement and should not act or rely on
it.
This announcement does not constitute a prospectus
and nothing herein contains an offering of securities. No one
should purchase any securities in the Company, except on the basis
of information in the prospectus published by the Company in
connection with the offering and admission of such securities to
trading and official listing on Nasdaq Copenhagen A/S. Copies of
the prospectus are available from the Company's registered office
and, subject to certain exceptions, on the website of the
Company.
The Joint Bookrunners and their affiliates are
acting exclusively for the Company and the Selling Shareholders and
no-one else in connection with the offering. They will not regard
any other person as their respective clients in relation to the
offering and will not be responsible to anyone other than the
Company and the Selling Shareholders for providing the protections
afforded to their respective clients, nor for providing advice in
relation to the offering, the contents of this announcement or any
transaction, arrangement or other matter referred to herein.
In connection with the offering, the Joint
Bookrunners and any of their affiliates, acting as investors for
their own accounts, may purchase shares and in that capacity may
retain, purchase, sell, offer to sell or otherwise deal for their
own accounts in such shares and other securities of the Company or
related investments in connection with the offering or otherwise.
Accordingly, references in the prospectus, to the shares being
issued, offered, acquired, placed or otherwise dealt in should be
read as including any issue or offer to, or acquisition, placing or
dealing by, such Joint Bookrunners and any of their affiliates
acting as investors for their own accounts. The Joint Bookrunners
do not intend to disclose the extent of any such investment or
transactions otherwise than in accordance with any legal or
regulatory obligations to do so.
In connection with the offering, Carnegie (the
"Stabilising Manager") (or persons acting on behalf of the
Stabilising Manager) may over-allot securities or effect
transactions with a view to supporting the market price of the
securities at a level higher than that which might otherwise
prevail. However, there is no assurance that the Stabilising
Manager (or persons acting on behalf of the Stabilising Manager)
will undertake stabilisation actions. Any stabilisation action may
begin on or after the date of commencement of trading and official
listing of the securities on Nasdaq Copenhagen A/S and, if begun,
may be ended at any time, but it must end no later than 30 days
after the date of commencement of trading and official listing of
the securities.
Matters discussed in this release may constitute
forward-looking statements. Forward-looking statements are
statements that are not historical facts and that can be identified
by words such as "believe", "expect", "anticipate", "intends",
"estimate", "will", "may", "continue", "should", and similar
expressions. The forward-looking statements in this announcement
are based upon various assumptions, many of which are based, in
turn, upon further assumptions. Although the Company believes that
these assumptions were reasonable when made, these assumptions are
inherently subject to significant known and unknown risks,
uncertainties, contingencies and other important factors which are
difficult or impossible to predict and are beyond its control. Such
risks, uncertainties, contingencies and other important factors
could cause actual events to differ materially from the
expectations expressed or implied in this release by such
forward-looking statements.
The information, opinions and forward-looking
statements contained in this announcement speak only as at its
date, and are subject to change without notice.
Company announcement 14-2017
Overallotment
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: TCM Group A/S via Globenewswire
Tycom Ltd (NYSE:TCM)
Historical Stock Chart
From Oct 2024 to Nov 2024
Tycom Ltd (NYSE:TCM)
Historical Stock Chart
From Nov 2023 to Nov 2024